Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial

被引:96
作者
Friedman, Deborah I. [1 ,2 ]
Quiros, Peter A. [3 ]
Subramanian, Prem S. [4 ,5 ,6 ]
Mejico, Luis J. [7 ,8 ]
Gao, Shan [9 ]
McDermott, Michael [10 ,11 ]
Wall, Michael [12 ,13 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA
[4] Univ Colorado, Denver Sch Med, Dept Ophthalmol, Aurora, CO USA
[5] Univ Colorado, Denver Sch Med, Dept Neurol, Aurora, CO USA
[6] Univ Colorado, Denver Sch Med, Dept Neurosurg, Aurora, CO USA
[7] SUNY UMU, Dept Neurol, Syracuse, NY USA
[8] SUNY UMU, Dept Ophthalmol, Syracuse, NY USA
[9] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY USA
[10] Univ Rochester, Sch Med & Dent, Ctr Neurotherapeut, Dept Biostat & Computat Biol, Rochester, NY USA
[11] Univ Rochester, Sch Med & Dent, Ctr Neurotherapeut, Dept Neurol, Rochester, NY USA
[12] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA
[13] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA
来源
HEADACHE | 2017年 / 57卷 / 08期
基金
美国国家卫生研究院;
关键词
idiopathic intracranial hypertension; headache; medication overuse; Headache Impact Test-6; PSEUDOTUMOR CEREBRI; PREVALENCE; MIGRAINE;
D O I
10.1111/head.13153
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-To characterize the phenotype, headache-related disability, medical co-morbidities, use of symptomatic headache medications, and headache response to study interventions in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Methods.-Patients with untreated IIH and mild vision loss enrolled in the IIHTT and randomized to acetazolamide (ACZ) and weight loss or placebo (PLB) and weight loss had prospective assessment of headache disability using the Headache Impact Test-6 (HIT-6) questionnaire. Subjects with headache at the baseline visit were assigned a headache phenotype using the International Classification for Headache Disorders version 3 beta (ICHD-3b). Medication overuse was determined using the participants' reported medication use for the preceding month and ICHD-3b thresholds for diagnosing medication overuse headache. We investigated relationships between headache disability and various other clinical characteristics at baseline and at 6 months. Results.-Headache was present in 139 (84%) of the 165 enrollees at baseline. The most common headache phenotypes were migraine (52%), tension-type headache (22%), probable migraine (16%), and probable tension-type headache (4%). Fifty-one (37%) participants overused symptomatic medications at baseline, most frequently simple analgesics. A similar amount of improvement in the adjusted mean (6 standard error) HIT-6 score occurred in the ACZ (-9.56 +/- 1.05) and PLB groups (-9.11 +/- 1.14) at 6 months (group difference -0.45, 95% CI -3.50 to 2.60, P=.77). Headache disability did not correlate with any of the studies, variables of interest, which included: the lumbar puncture opening pressure at baseline or at 6 months, body mass index, the amount of weight lost, papilledema grade, perimetric mean deviation, or the use of hormonal contraception. Headache disability was significantly associated with patient-reported quality of life in the physical, mental, and visual domains. Conclusions.-Headache was common, of varied character, disabling, and associated with poorer quality of life in our cohort of patients with mild visual impairment. The lack of correlation between headache disability and cerebrospinal fluid (CSF) pressure at baseline and at the end of the randomized phase of the study implies that headache in IIH may be related to factors other than intracranial hypertension, and that specific headache treatment is needed in addition to therapies directed at lowering CSF pressure.
引用
收藏
页码:1195 / 1205
页数:11
相关论文
共 50 条
[31]   Idiopathic intracranial hypertension [J].
Digre, Kathleen B. .
BRITISH MEDICAL JOURNAL, 2010, 341
[32]   Idiopathic intracranial hypertension [J].
Kathleen B. Digre .
Current Treatment Options in Neurology, 1999, 1 (1) :74-81
[33]   Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension [J].
Daou, Badih J. ;
Sweid, Ahmad ;
Weinberg, Joshua H. ;
Starke, Robert M. ;
Sergott, Robert C. ;
Doermann, Allison S. ;
Hauge, Julie ;
Zanaty, Mario ;
Chalouhi, Nohra ;
Gooch, Reid ;
Herial, Nabeel ;
Zarzour, Hekmat ;
Jabbour, Pascal ;
Rosenwasser, Robert H. ;
Tjoumakaris, Stavropoula .
WORLD NEUROSURGERY, 2020, 142 :E73-E80
[34]   Idiopathic intracranial Hypertension [J].
Baeuerle, J. ;
Egger, K. ;
Harloff, A. .
NERVENARZT, 2017, 88 (02) :191-200
[35]   Novel Approaches to the Treatment of Idiopathic Intracranial Hypertension [J].
Subramanian, Prem S. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2024, 24 (08) :265-272
[36]   Bariatric surgery for the treatment of idiopathic intracranial hypertension [J].
Fridley, Jared ;
Foroozan, Rod ;
Sherman, Vadim ;
Brandt, Mary L. ;
Yoshor, Daniel .
JOURNAL OF NEUROSURGERY, 2011, 114 (01) :34-39
[37]   Idiopathic intracranial hypertension [J].
Robert K. Shin ;
Laura J. Balcer .
Current Treatment Options in Neurology, 2002, 4 (4) :297-305
[38]   Idiopathic Intracranial Hypertension [J].
Melissa W. Ko .
Current Treatment Options in Neurology, 2011, 13 :101-108
[39]   Idiopathic intracranial hypertension [J].
Friedman D.I. .
Current Pain and Headache Reports, 2007, 11 (1) :62-68
[40]   Idiopathic Intracranial Hypertension - Challenges and Pearls [J].
Rohit, Wadikhaye ;
Rajesh, Alugolu ;
Mridula, Rukmini ;
Jabeen, Shaik A. .
NEUROLOGY INDIA, 2021, 69 :S420-S428